Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.

Radiosensitizing effect of curcumin-loaded lipid nanoparticles in breast cancer cells

Open access

Abstract

In breast cancer (BC) care, radiotherapy is considered an efficient treatment, prescribed both for controlling localized tumors or as a therapeutic option in case of inoperable, incompletely resected or recurrent tumors. However, approximately 90% of BC-related deaths are due to the metastatic tumor progression. Then, it is strongly desirable to improve tumor radiosensitivity using molecules with synergistic action. The main aim of this study is to develop curcumin-loaded solid nanoparticles (Cur-SLN) in order to increase curcumin bioavailability and to evaluate their radiosensitizing ability in comparison to free curcumin (free-Cur), by using an in vitro approach on BC cell lines. In addition, transcriptomic and metabolomic profiles, induced by Cur-SLN treatments, highlighted networks involved in this radiosensitization ability. The non tumorigenic MCF10A and the tumorigenic MCF7 and MDA-MB-231 BC cell lines were used. Curcumin-loaded solid nanoparticles were prepared using ethanolic precipitation and the loading capacity was evaluated by UV spectrophotometer analysis. Cell survival after treatments was evaluated by clonogenic assay. Dose–response curves were generated testing three concentrations of free-Cur and Cur-SLN in combination with increasing doses of IR (2–9 Gy). IC 50 value and Dose Modifying Factor (DMF) was measured to quantify the sensitivity to curcumin and to combined treatments. A multi-“omic” approach was used to explain the Cur-SLN radiosensitizer effect by microarray and metobolomic analysis. We have shown the efficacy of the Cur-SLN formulation as radiosensitizer on three BC cell lines. The DMFs values, calculated at the isoeffect of SF = 50%, showed that the Luminal A MCF7 resulted sensitive to the combined treatments using increasing concentration of vehicled curcumin Cur-SLN (DMF: 1,78 with 10 µM Cur-SLN.) Instead, triple negative MDA-MB-231 cells were more sensitive to free-Cur, although these cells also receive a radiosensitization effect by combination with Cur-SLN (DMF: 1.38 with 10 µM Cur-SLN). The Cur-SLN radiosensitizing function, evaluated by transcriptomic and metabolomic approach, revealed anti-oxidant and anti-tumor effects. Curcumin loaded- SLN can be suggested in future preclinical and clinical studies to test its concomitant use during radiotherapy treatments with the double implications of being a radiosensitizing molecule against cancer cells, with a protective role against IR side effects.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-019-47553-2

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Dose-Response curves of MCF10A. Dose-Response curves of MCF10A cells subjected to increasing doses of IR with or without 2.5 µM of free-Cur and Cur-SLN.
Figure 1 Dose-Response curves of MCF10A. Dose-Response curves of MCF10A cells subjected to increasing doses of IR with or without 2.5 µM of free-Cur and Cur-SLN.CC BY · PubMed Central
Figure 2 Dose-Response curves of MCF7. Dose-Response curves of MCF7 BC cells subjected to increasing doses of IR with or without 2.5 µM of free-Cur and Cur-SLN.
Figure 2 Dose-Response curves of MCF7. Dose-Response curves of MCF7 BC cells subjected to increasing doses of IR with or without 2.5 µM of free-Cur and Cur-SLN.CC BY · PubMed Central
Figure 3 Dose-Response curves of MDA-MB-231. Dose-Response curves of MDA-MB-231 BC cells subjected to increasing doses of IR with or without 2.5 µM of free-Cur and Cur-SLN.
Figure 3 Dose-Response curves of MDA-MB-231. Dose-Response curves of MDA-MB-231 BC cells subjected to increasing doses of IR with or without 2.5 µM of free-Cur and Cur-SLN.CC BY · PubMed Central
Figure 4 Determination of intracellular ROS production. Oxidative stress quantification performed measuring intracellular ROS levels with the DCFH-DA molecular probe in the MCF10A, MDA-MB-231 and MCF7 cell lines 24 hrs after treatments with 2 Gy, 2 Gy + Cur-SLN, Cur-SLN. The significance level respect to the control sample was set to *P < 0.05.
Figure 4 Determination of intracellular ROS production. Oxidative stress quantification performed measuring intracellular ROS levels with the DCFH-DA molecular probe in the MCF10A, MDA-MB-231 and MCF7 cell lines 24 hrs after treatments with 2 Gy, 2 Gy + Cur-SLN, Cur-SLN. The significance level respect to the control sample was set to *P < 0.05.CC BY · PubMed Central
Figure 5 Venn diagrams of unique and shared differentially expressed genes by breast cell lines after combined treatments with IR/2,5 µM Cur-SLN. (A) A 51-gene signature of shared deregulate genes after Cur-SLN treatment was selected among MCF10A, MCF7 and MDA-MB-231 breast cell lines. The top-GO Biological processes were also displayed. (B) A 263-gene signature of common deregulated genes was selected for MCF7 and MDA-MB-231 BC cell lines and the top-GO biological processes regulated by these genes, were also reported in the figure.
Figure 5 Venn diagrams of unique and shared differentially expressed genes by breast cell lines after combined treatments with IR/2,5 µM Cur-SLN. (A) A 51-gene signature of shared deregulate genes after Cur-SLN treatment was selected among MCF10A, MCF7 and MDA-MB-231 breast cell lines. The top-GO Biological processes were also displayed. (B) A 263-gene signature of common deregulated genes was selected for MCF7 and MDA-MB-231 BC cell lines and the top-GO biological processes regulated by these genes, were also reported in the figure.CC BY · PubMed Central
Figure 6 Comparative analysis of MCF10A, MCF7 and MDA-MB-231 by Hierarchical Clustering and untargeted enrichment plots. (A) Comparative analysis of MCF10A, MCF7 and MDA-MB-231 by Hierarchical Clustering. (B) Untargeted enrichment plot displaying increased metabolites levels in MCF7 and MDA-MB-231 under 2 Gy and 2 Gy/Cur-SLN treatments, respect to MCF10A under the same condition. (C) Untargeted enrichment plot displaying decreased metabolites levels in MCF7 and MDA-MB-231 under 2 Gy and 2 Gy/Cur-SLN treatments, respect to MCF10A under the same condition.
Figure 6 Comparative analysis of MCF10A, MCF7 and MDA-MB-231 by Hierarchical Clustering and untargeted enrichment plots. (A) Comparative analysis of MCF10A, MCF7 and MDA-MB-231 by Hierarchical Clustering. (B) Untargeted enrichment plot displaying increased metabolites levels in MCF7 and MDA-MB-231 under 2 Gy and 2 Gy/Cur-SLN treatments, respect to MCF10A under the same condition. (C) Untargeted enrichment plot displaying decreased metabolites levels in MCF7 and MDA-MB-231 under 2 Gy and 2 Gy/Cur-SLN treatments, respect to MCF10A under the same condition.CC BY · PubMed Central
Figure 7 Hierarchical Clustering analysis and untargeted enrichment plots of MCF10A, MCF7 and MDA-MB-231 exposed to 2 Gy vs 2 Gy/Cur-SLN treatments. (A) Hierarchical Clustering analysis and untargeted enrichment plots of MCF10A, exposed to 2 Gy vs 2 Gy/Cur-SLN treatments. (B) Hierarchical Clustering analysis and untargeted enrichment plots of MCF7, exposed to 2 Gy vs 2 Gy/Cur-SLN treatments. (C) Hierarchical Clustering analysis and untargeted enrichment plots of MDA-MB-231, exposed to 2 Gy vs 2 Gy/Cur-SLN treatments.
Figure 7 Hierarchical Clustering analysis and untargeted enrichment plots of MCF10A, MCF7 and MDA-MB-231 exposed to 2 Gy vs 2 Gy/Cur-SLN treatments. (A) Hierarchical Clustering analysis and untargeted enrichment plots of MCF10A, exposed to 2 Gy vs 2 Gy/Cur-SLN treatments. (B) Hierarchical Clustering analysis and untargeted enrichment plots of MCF7, exposed to 2 Gy vs 2 Gy/Cur-SLN treatments. (C) Hierarchical Clustering analysis and untargeted enrichment plots of MDA-MB-231, exposed to 2 Gy vs 2 Gy/Cur-SLN treatments.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 55 references

Cited by

See all 116

Metadata

Authors
Minafra, L., Porcino, N., Bravatà, V., Gaglio, D., Bonanomi, M., Amore, E., Cammarata, F. P., Russo, G., Militello, C., Savoca, G., Baglio, M., Abbate, B., Iacoviello, G., Evangelista, G., Gilardi, M. C., Bondì, M. L., & Forte, G. I.
Affiliations
  • Institute of Molecular Bioimaging and Physiology (IT)
  • University of Milano-Bicocca (IT)
  • Institute of Nanostructured Materials (IT)
Corresponding author
Bravatà, Valentina
Venue
Scientific Reports
Published
2019-07-31
Volume
9
Issue
1
Pages
11134-11134
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2754565030
Cited by
108
References
55
Citations by year
2026: 12 · 2025: 11 · 2024: 14 · 2023: 14 · 2022: 16 · 2021: 24 · 2020: 12 · 2019: 4
FWCI
4.84
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • BOA (University of Milano-Bicocca) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
Università degli Studi di Palermo
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Curcumin's Biomedical Applications
  • Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
  • Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
Keywords
curcumin, solid lipid nanoparticles, radiosensitization, breast cancer, radiotherapy, dose modification factor, MCF-7 cells, MDA-MB-231 cells, MCF10A cells, gene expression profiling, metabolite profiling, antioxidant activity, triple-negative breast cancer, luminal A, curcumin bioavailability, clonogenic survival
MeSH terms
Antineoplastic Agents, Breast Neoplasms, Cell Survival, Curcumin, Drug Carriers, Female, Humans, Lipids, Particle Size, Radiation-Sensitizing Agents, Drug Delivery Systems, Apoptosis, Cell Line, Tumor, Nanoparticles, MCF-7 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Radiosensitizing effect of curcumin-loaded lipid nanoparticles in breast cancer cells. https://app.cochat.ai/papers/10.1038/s41598-019-47553-2
The paper
Minafra, L., Porcino, N., Bravatà, V., Gaglio, D., Bonanomi, M., Amore, E., Cammarata, F. P., Russo, G., Militello, C., Savoca, G., Baglio, M., Abbate, B., Iacoviello, G., Evangelista, G., Gilardi, M. C., Bondì, M. L., & Forte, G. I. (2019). Radiosensitizing effect of curcumin-loaded lipid nanoparticles in breast cancer cells. Scientific Reports. https://doi.org/10.1038/s41598-019-47553-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.